Recent research on human jejunal L-cells revealed dysregulation of enteroendocrine differentiation markers associated with lower L-cell density in individuals with obesity and type 2 diabetes, which ultimately resulted in decreased GLP-1-positive cell density and may diminish the ability to produce GLP-1 in response to food [91]. The gene discussed is GCG; the disease is obesity disorder.